Symphony Q1FY27: Margin gains, BISP scale, and overseas divergence
Ask Iris
Frequently Asked Questions
Consolidated revenue from operations was 378 crore (up 8% YoY), EBITDA was 48 crore (up 26% YoY), and PAT was 40 crore (down 5% YoY).
The company cited a 5 crore one-off non-cash expense in the June 2026 quarter and lower other income versus the prior year quarter (13 crore vs 22 crore).
Standalone revenue was 241 crore (up 5% YoY), EBITDA was 30 crore (up 25% YoY), and PAT was 28 crore (down 24% YoY), with the PAT decline influenced by higher other income in the prior year quarter.
BISP refers to Beyond India Summer Products. The presentation stated BISP delivered 560 crore and contributed 48% of trailing twelve month consolidated revenue. On a standalone trailing twelve month basis, BISP revenue was stated at 179 crore (23%).
Bonaire USA reported revenue of 36 crore (vs 27 crore) and EBITDA of 18 crore (vs 7 crore). IMPCO Mexico reported revenue of 54 crore (vs 66 crore) and EBITDA of 3 crore (vs 7 crore). GSK China reported revenue of 34 crore (vs 24 crore) and EBITDA of 6 crore (vs 2 crore). CTPL Australia reported revenue of 27 crore (vs 31 crore) and EBITDA of negative 4 crore (vs negative 2 crore).
Management said it expects short-term margin pressure due to elevated costs and will pass on some, but not all, increases. It stated no price hikes were taken yet in household coolers, while 7% to 10% hikes were taken in other segments.
Management stated there will be no further capital allocation to CTPL Australia, and that impairment/write-offs were recorded in FY26, with nothing new planned operationally beyond continuing existing efforts.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
